Renal Cancer - Results from #4300

Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease August 9, 2018

Palliative care: the need of the modern era August 9, 2018

Infectious Outcomes from Renal Tumor Ablation: Prophylactic Antibiotics or Not? August 9, 2018

Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma August 9, 2018

Sunitinib prior to planned nephrectomy in metastatic renal cell carcinoma: angiogenesis biomarkers predict clinical outcome in the prospective Phase 2 PREINSUT trial August 9, 2018

Contemporary management of advanced renal cell carcinoma August 9, 2018

Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry August 8, 2018

Determinants of Active Surveillance in Patients with Small Renal Masses August 8, 2018

Classification tree for the prediction of malignant disease and the prediction of non-diagnostic biopsies in patients with small renal masses August 8, 2018

Primary renal angiosarcoma August 8, 2018

Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations Between mRNA-Based Subtyping and CT Imaging Features August 7, 2018

Functional Parenchymal Volume-Based Spectrum Score is Able to Quantify Ischemic Injury after Partial Nephrectomy August 7, 2018

Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers August 7, 2018

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer) August 7, 2018

Germline SDHA mutations in children and adults with cancer August 6, 2018

Characterization of the Breast Cancer Resistance Protein (BCRP/ABCG2) in clear cell renal cell carcinoma August 6, 2018

Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy? August 6, 2018

Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET. August 6, 2018

Quality of life outcomes in patients with localised renal cancer: a literature review August 6, 2018

Nivolumab Treatment for Cancers in the HIV-infected Population August 3, 2018

Page 216 of 456